These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8438557)

  • 21. Secretory meningioma with severe perifocal edema--case report.
    Tsuzuki N; Nakau H; Sugaya M; Hashizume K; Matsukuma S; Wada R; Kuwabara N
    Neurol Med Chir (Tokyo); 1997 Aug; 37(8):620-3. PubMed ID: 9301199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and histological features of multiple meningiomas compared with solitary meningiomas.
    Huang H; Buhl R; Hugo HH; Mehdorn HM
    Neurol Res; 2005 Apr; 27(3):324-32. PubMed ID: 15845217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four cases of distinctive meningiomas with Zellballen growth pattern.
    Dong Y; Zhou X; Wu B; Wang J; Ma H; Zhou H; Jiang S; Lu G; Hu Q
    APMIS; 2009 Dec; 117(12):936-40. PubMed ID: 20078559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pericellular deposition of basement membrane material in myxoid meningioma: immunohistochemical evidence for unbalanced production of type IV collagen and laminin.
    Kimura Y; Matsumae M; Tsutsumi Y
    Pathol Int; 1998 Jan; 48(1):53-7. PubMed ID: 9589465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microcystic meningiomas--an unusual morphological variant of meningiomas.
    Ng HK; Tse CC; Lo ST
    Histopathology; 1989 Jan; 14(1):1-9. PubMed ID: 2925174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of bone-related protein messenger RNA in human meningiomas: possible involvement of osteopontin in development of psammoma bodies.
    Hirota S; Nakajima Y; Yoshimine T; Kohri K; Nomura S; Taneda M; Hayakawa T; Kitamura Y
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):698-703. PubMed ID: 7666059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucinous meningioma. Report of an unusual variant of meningioma that may mimic metastatic mucin-producing carcinoma.
    Berho M; Suster S
    Am J Surg Pathol; 1994 Jan; 18(1):100-6. PubMed ID: 8279622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vacuolated meningioma. A light and electron microscopic study.
    Eimoto T; Hashimoto K
    Acta Pathol Jpn; 1977 Jul; 27(4):557-66. PubMed ID: 910629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereological estimation of nuclear volume in benign and atypical meningiomas.
    Madsen C; Schrøder HD
    APMIS; 1993 Jan; 101(1):23-6. PubMed ID: 8457322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the use of proliferation markers in human meningiomas.
    Torp SH
    Clin Neuropathol; 2021; 40(1):57-59. PubMed ID: 32831160
    [No Abstract]   [Full Text] [Related]  

  • 31. [On diagnostics of malignant meningioma and invasive meningioma].
    Zhang S; Meng H; Gui Y; Chen L; Zhao T; Zhang X; Li G; Yang G
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Jun; 27(2):192-5. PubMed ID: 9389041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory meningiomas.
    Colakoğlu N; Demirtaş E; Oktar N; Yüntem N; Islekel S; Ozdamar N
    J Neurooncol; 2003 May; 62(3):233-41. PubMed ID: 12777074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerosing meningioma: immunohistochemical analysis of five cases.
    Kim NR; Im SH; Chung CK; Suh YL; Choe G; Chi JG
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):126-35. PubMed ID: 15043710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG; Shishkina LV; Golanov AV
    Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grading of meningiomas.
    Sekhar LN; Levine ZT; Sarma S
    J Clin Neurosci; 2001 May; 8 Suppl 1():1-7. PubMed ID: 11386816
    [No Abstract]   [Full Text] [Related]  

  • 37. Meningiomas: A continuum of progress in risk-stratification.
    Chacko G
    Neurol India; 2018; 66(1):161-162. PubMed ID: 29322979
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal amianthoid collagen fibers in meningioma.
    Harkin JC; Leonard GL
    Acta Neuropathol; 1988; 76(6):638-9. PubMed ID: 3201928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Meningioma].
    Mori K; Ueda J; Fujita S; Arita N
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():133-8. PubMed ID: 16201513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.